CYB561 is a potential therapeutic target for breast cancer and is associated with immune cell infiltration
Elevated CYB561 expression suggests a poor prognosis for patients with BC and is associated with macrophage M2 polarization in the BC microenvironment. Therefore, CYB561 could potentially serve as a therapeutic target for BC treatment.
Authors
- Jian Zhuo (ORCID: https://orcid.org/0000-0002-7903-315X)
- Luxian Dai
- Rao Wang (ORCID: https://orcid.org/0000-0003-1058-7442)
- Hanyu Yao
- Ankang Sheng
- He Li (ORCID: https://orcid.org/0000-0001-7459-9202)
- Weiguang Liu (ORCID: https://orcid.org/0000-0002-3385-5051)
- Yubao Tang
- Yang Xiao-hong (ORCID: https://orcid.org/0000-0001-8948-5187)
- Yanchun Zhao
- Ruiying Hao
- Zilin Zheng
Institutions
- Hebei University of Engineering (CN)
- Northern Jiangsu People's Hospital (CN)
- Affiliated Hospital of Hebei University (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1186/s40001-024-02010-3
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.47